Found: 6
Select item for more details and to access through your institution.
Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1080, doi. 10.1007/s10637-022-01271-1
- By:
- Publication type:
- Article
Gemcitabine, carboplatin and veliparib in multiple relapsed/refractory germ cell tumours: The GCT-SK-004 phase II trial.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1664, doi. 10.1007/s10637-021-01130-5
- By:
- Publication type:
- Article
Phase II study of avelumab in multiple relapsed/refractory germ cell cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 748, doi. 10.1007/s10637-019-00805-4
- By:
- Publication type:
- Article
HELICOBACTER PYLORI A KARCINÓM ŽALÚDKA.
- Published in:
- Zdravotnicke listy, 2019, v. 7, n. 1, p. A32
- By:
- Publication type:
- Article
Long-term sexual functioning in germ-cell tumor survivors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Fibrillin-1 (FBN-1) a new marker of germ cell neoplasia in situ.
- Published in:
- 2016
- By:
- Publication type:
- journal article